Shenzhen University General Hospital
Shenzhen University General Hospital
Shenzhen, Guangdong, China5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-02-04 | NCT07172204 | |
| Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) | acute myeloid leukemia | Enrolling by invitation | Early phase 1 | 2025-08-28 | NCT06499025 | |
| the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia | β-thalassemia | Recruiting | Early phase 1 | 2024-11-29 | NCT05864170 | |
| BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2024-10-16 | NCT06644443 | |
| Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA) | colorectal adenoma | Recruiting | Phase 2 | 2024-07-15 | NCT06205862 |